Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Methodology
Signal backtests
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

GV 2016 GP, L.L.C. — ACTELIS NETWORKS INC insider · InsiderLens

/ / GV 2016 GP, L.L.C.

GV 2016 GP, L.L.C.

10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
10% owner at ARMO BioSciences, Inc. · on record since Jan 30, 2018
10% owner at Arcus Biosciences, Inc. · on record since Mar 19, 2018
10% owner at Dianthus Therapeutics, Inc. /DE/ · on record since Jun 27, 2018
10% owner at Decibel Therapeutics, Inc. · on record since Feb 17, 2021
10% owner at IonQ, Inc. · on record since Oct 4, 2021
10% owner at Starco Brands, Inc. · on record since Feb 27, 2023

Insider trading activity of GV 2016 GP, L.L.C.

No transactions on record for GV 2016 GP, L.L.C..

Track record of GV 2016 GP, L.L.C.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of GV 2016 GP, L.L.C.

Co-insiders of GV 2016 GP, L.L.C.

GV 2016 GP, L.P.ACTELIS NETWORKS INC +6
GV 2016, L.P.ACTELIS NETWORKS INC +6
Alphabet Inc.ACTELIS NETWORKS INC +5
ORBIMED ADVISORS LLCACTELIS NETWORKS INC +2
BASKETT FORESTACTELIS NETWORKS INC +1
BYERS BLAKEDianthus Therapeutics, Inc. /DE/ +1
Florence Anthony A. Jr.ACTELIS NETWORKS INC +1
GORDON CARL LACTELIS NETWORKS INC +1
GV 2017 GP, L.L.C.Arcus Biosciences, Inc. +1
GV 2017 GP, L.P.Arcus Biosciences, Inc. +1
GV 2017, L.P.Arcus Biosciences, Inc. +1
GV 2019 GP, L.L.C.Decibel Therapeutics, Inc. +1
GV 2019 GP, L.P.Decibel Therapeutics, Inc. +1
GV 2019, L.P.Decibel Therapeutics, Inc. +1
Makhzoumi MohamadACTELIS NETWORKS INC +1
OrbiMed Capital GP IV LLCACTELIS NETWORKS INC +1
SANDELL SCOTT DACTELIS NETWORKS INC +1
Sonsini Peter W.ACTELIS NETWORKS INC +1
Decibel Therapeutics, Inc.
a16z Seed-III, LLCStarco Brands, Inc.
Acosta Dean P.IonQ, Inc.

This page republishes public regulatory disclosures.

Adams JanACTELIS NETWORKS INC

Aharon EyalACTELIS NETWORKS INC

AH Equity Partners III, L.L.C.Starco Brands, Inc.

AH Equity Partners IV, L.L.C.Starco Brands, Inc.

AH Equity Partners IV (Parallel), L.L.C.Starco Brands, Inc.

AH Parallel Fund IV-A, L.P.Starco Brands, Inc.

AH Parallel Fund IV-B, L.P.Starco Brands, Inc.

AH Parallel Fund IV, L.P.Starco Brands, Inc.

AH Parallel Fund IV-Q, L.P.Starco Brands, Inc.

Alameddine RimaIonQ, Inc.

Albers Jeffrey W.Dianthus Therapeutics, Inc. /DE/

Alexandria Venture Investments, LLCACTELIS NETWORKS INC

Altit YaronACTELIS NETWORKS INC

Anderson DarlaIonQ, Inc.

Andreessen Horowitz Fund III-A, L.P.Starco Brands, Inc.

Andreessen Horowitz Fund III-B, L.P.Starco Brands, Inc.

Andreessen Horowitz Fund III, L.P.Starco Brands, Inc.

Andreessen Horowitz Fund III-Q, L.P.Starco Brands, Inc.

Andreessen Horowitz Fund IV-A, L.P.Starco Brands, Inc.

Andreessen Horowitz Fund IV-B, L.P.Starco Brands, Inc.

Andreessen Horowitz Fund IV, L.P.Starco Brands, Inc.

Andreessen Horowitz Fund IV-Q, L.P.Starco Brands, Inc.

ANDREESSEN MARC LStarco Brands, Inc.

Anna-Maria & Stephen Kellen Foundation, Inc.ACTELIS NETWORKS INC

Atlas Venture Associates Opportunity I, LLCDianthus Therapeutics, Inc. /DE/

Atlas Venture Associates Opportunity I, L.P.Dianthus Therapeutics, Inc. /DE/

Atlas Venture Associates X, LLCDianthus Therapeutics, Inc. /DE/

ATLAS VENTURE ASSOCIATES X, L.P.Dianthus Therapeutics, Inc. /DE/

Atlas Venture Fund X, L.P.Dianthus Therapeutics, Inc. /DE/

Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters